Immune tolerance occurs, leading to immune escape of tumor cells [4], and in the process of killing tumor cells, the most central role in TME is played by CD8+ T cells [5], the quality and quantity of which are critical for immunotherapeutic efficacy [6]. Here, CD8A is linked to neoplasm.